Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22:9694–705.
Article PubMed PubMed Central Google Scholar
Adamska A, Domenichini A, Falasca M. Pancreatic ductal adenocarcinoma: current and evolving therapies. Int J Mol Sci. 2017;18:67.
Park W, Chawla A, O’Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326:851–62.
Article CAS PubMed PubMed Central Google Scholar
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–21.
Article CAS PubMed Google Scholar
Gutierrez ML, Munoz-Bellvis L, Orfao A. Genomic heterogeneity of pancreatic ductal adenocarcinoma and its clinical impact. Cancers (Basel). 2021;13:87.
Samuel N, Hudson TJ. The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;9:77–87.
Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10:10–27.
Article PubMed PubMed Central Google Scholar
Bosetti C, Lucenteforte E, Silverman DT, et al. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case–Control Consortium (Panc4). Ann Oncol. 2012;23:1880–8.
Article CAS PubMed Google Scholar
Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 2004;64:2634–8.
Article CAS PubMed Google Scholar
Costache MI, Costache CA, Dumitrescu CI, et al. Which is the best imaging method in pancreatic adenocarcinoma diagnosis and staging—CT, MRI or EUS? Curr Health Sci J. 2017;43:132–6.
CAS PubMed PubMed Central Google Scholar
Gudmundsdottir H, Yonkus JA, Alva-Ruiz R, et al. Yield of staging laparoscopy for pancreatic cancer in the modern era: analysis of more than 1,000 consecutive patients. J Am Coll Surg. 2023;237:49–57.
Article PubMed PubMed Central Google Scholar
Poruk KE, Gay DZ, Brown K, et al. The clinical utility of CA 19–9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med. 2013;13:340–51.
CAS PubMed PubMed Central Google Scholar
Meng Q, Shi S, Liang C, et al. Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis. Onco Targets Ther. 2017;10:4591–8.
Article PubMed PubMed Central Google Scholar
Akimoto S, Banshodani M, Nishihara M, et al. Acute cholecystitis with significantly elevated levels of serum carbohydrate antigen 19–9. Case Rep Gastroenterol. 2016;10:410–6.
Article PubMed PubMed Central Google Scholar
Mann DV, Edwards R, Ho S, et al. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol. 2000;26:474–9.
Article CAS PubMed Google Scholar
Turtel PS, Kreel I, Israel J, et al. Elevated CA19-9 in a case of Mirizzi’s syndrome. Am J Gastroenterol. 1992;87:355–7.
Albert MB, Steinberg WM, Henry JP. Elevated serum levels of tumor marker CA19-9 in acute cholangitis. Dig Dis Sci. 1988;33:1223–5.
Article CAS PubMed Google Scholar
El Kaoutari A, Fraunhoffer NA, Audebert S, et al. Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers. EBioMedicine. 2023;92: 104634.
Article PubMed PubMed Central Google Scholar
Zhao R, Ren S, Li C, et al. Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study. Cancer Med. 2023;12:5158–71.
Article CAS PubMed Google Scholar
Wolrab D, Jirasko R, Cifkova E, et al. Lipidomic profiling of human serum enables detection of pancreatic cancer. Nat Commun. 2022;13:124.
Article CAS PubMed PubMed Central Google Scholar
Wang G, Yao H, Gong Y, et al. Metabolic detection and systems analyses of pancreatic ductal adenocarcinoma through machine learning, lipidomics, and multi-omics. Sci Adv. 2021;7:2724.
Byeon SK, Madugundu AK, Garapati K, et al. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study. Lancet Digit Health. 2022;4:e632–45.
Article CAS PubMed PubMed Central Google Scholar
Lofgren L, Stahlman M, Forsberg GB, et al. The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma. J Lipid Res. 2012;53:1690–700.
Article PubMed PubMed Central Google Scholar
Breiman L. Random forests. J Mach Learn. 2001;45:5–32.
Matsuki K, Kuperman V, Van Dyke JA. The random forests statistical technique: an examination of its value for the study of reading. Sci Stud Read. 2016;20:20–33.
Article PubMed PubMed Central Google Scholar
Kohler N, Rose TD, Falk L, et al. Investigating global lipidome alterations with the lipid network explorer. Metabolites. 2021;11:79.
Gaud C, Nguyen A, et al. BioPAN: a web-based tool to explore mammalian lipidome metabolic pathways on LIPID MAPS. F1000Res. 2021;10:4.
Article PubMed PubMed Central Google Scholar
Gao J, Tarcea VG, Karnovsky A, et al. Metscape: a cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks. Bioinformatics. 2010;26:971–3.
Article CAS PubMed PubMed Central Google Scholar
Kolberg L, Raudvere U, Kuzmin I, et al. g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res. 2023;51:W207–12.
Article CAS PubMed PubMed Central Google Scholar
Uppal K, Ma C, Go YM, et al. xMWAS: a data-driven integration and differential network analysis tool. Bioinformatics. 2018;34:701–2.
Article CAS PubMed Google Scholar
Lei C, Hou Y, Chen J. Specificity protein 1-activated bone marrow stromal cell antigen 2 accelerates pancreatic cancer cell proliferation and migration. Exp Ther Med. 2021;22:1459.
留言 (0)